141 related articles for article (PubMed ID: 9290763)
1. Infiltrating recipient mesenchymal cells form the obliterative airway disease lesion and dramatically remodel graft tissue in a model of chronic lung rejection.
Brazelton TR; Shorthouse R; Huang X; Morris RE
Transplant Proc; 1997 Sep; 29(6):2614. PubMed ID: 9290763
[No Abstract] [Full Text] [Related]
2. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation.
Medoff BD; Seung E; Wain JC; Means TK; Campanella GS; Islam SA; Thomas SY; Ginns LC; Grabie N; Lichtman AH; Tager AM; Luster AD
J Exp Med; 2005 Jul; 202(1):97-110. PubMed ID: 15998790
[TBL] [Abstract][Full Text] [Related]
3. Small animal models of experimental obliterative bronchiolitis.
Jungraithmayr W; Jang JH; Schrepfer S; Inci I; Weder W
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):675-84. PubMed ID: 23392572
[TBL] [Abstract][Full Text] [Related]
4. Heterotopic tracheal transplantation animal model of bronchiolitis obliterans: a reproducible model.
Gómez-de-Antonio D; Campo-Cañaveral de la Cruz JL; Gonzalez-Lois C; Santos M; Millán I; Varela de Ugarte A
Ann Transplant; 2013 Dec; 18():661-70. PubMed ID: 24309319
[TBL] [Abstract][Full Text] [Related]
5. PLK1 Inhibition alleviates transplant-associated obliterative bronchiolitis by suppressing myofibroblast differentiation.
Yu J; Xu H; Cui J; Chen S; Zhang H; Zou Y; Zhao J; Le S; Jiang L; Chen Z; Liu H; Zhang D; Xia J; Wu J
Aging (Albany NY); 2020 Jun; 12(12):11636-11652. PubMed ID: 32541091
[TBL] [Abstract][Full Text] [Related]
6. Prevention of cytomegalovirus infection-enhanced experimental obliterative bronchiolitis by antiviral prophylaxis or immunosuppression in rat tracheal allografts.
Tikkanen JM; Kallio EA; Bruggeman CA; Koskinen PK; Lemström KB
Am J Respir Crit Care Med; 2001 Aug; 164(4):672-9. PubMed ID: 11520736
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
[TBL] [Abstract][Full Text] [Related]
8. Obliterative bronchiolitis in lung allografts removed at retransplant for intractable airway problems.
Akindipe O; Fernandez-Bussy S; Jantz M; Lu L; Deem A; Swafford W; Staples E; Baz M
Respirology; 2009 May; 14(4):601-5. PubMed ID: 19383111
[TBL] [Abstract][Full Text] [Related]
9. A novel charcoal-induced model of obliterative bronchiolitis-like lesions: implications of chronic nonspecific airway inflammation in the development of posttransplantation obliterative bronchiolitis.
Lee AG; Wagner FM; Chen MF; Serrick C; Giaid A; Shennib H
J Thorac Cardiovasc Surg; 1998 Apr; 115(4):822-7. PubMed ID: 9576217
[TBL] [Abstract][Full Text] [Related]
10. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways.
Hertz MI; Jessurun J; King MB; Savik SK; Murray JJ
Am J Pathol; 1993 Jun; 142(6):1945-51. PubMed ID: 8506960
[TBL] [Abstract][Full Text] [Related]
11. The macrolide clarithromycin inhibits experimental post-transplant bronchiolitis obliterans.
Remund K; Rechsteiner T; Guo Z; Rentsch K; Boehler A
Exp Lung Res; 2009 Dec; 35(10):830-40. PubMed ID: 19995277
[TBL] [Abstract][Full Text] [Related]
12. Obliterative bronchiolitis or chronic lung allograft rejection: a basic science review.
Neuringer IP; Chalermskulrat W; Aris R
J Heart Lung Transplant; 2005 Jan; 24(1):3-19. PubMed ID: 15653373
[No Abstract] [Full Text] [Related]
13. Lung transplantation in the fischer 344-wistar kyoto strain combination is a relevant experimental model to study the development of bronchiolitis obliterans in the rat.
von Süßkind-Schwendi M; Ruemmele P; Schmid C; Hirt SW; Lehle K
Exp Lung Res; 2012 Apr; 38(3):111-23. PubMed ID: 22394285
[TBL] [Abstract][Full Text] [Related]
14. Obliterative bronchiolitis: prevention.
Kallio EA; Koskinen PK; Tikkanen JM; Lemström KB
Transplant Proc; 2001; 33(1-2):1617-9. PubMed ID: 11267443
[No Abstract] [Full Text] [Related]
15. LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats.
Tu ZL; Zhou ZY; Xu HC; Cao JL; Ye P; Wang LM; Lv W; Hu J
J Cardiothorac Surg; 2017 May; 12(1):43. PubMed ID: 28545478
[TBL] [Abstract][Full Text] [Related]
16. PG490-88, a derivative of triptolide, attenuates obliterative airway disease in a mouse heterotopic tracheal allograft model.
Leonard CT; Soccal PM; Berry GJ; Doyle RL; Theodore J; Duncan SR; Rosen GD
J Heart Lung Transplant; 2002 Dec; 21(12):1314-8. PubMed ID: 12490278
[TBL] [Abstract][Full Text] [Related]
17. Chronic rejection in single-lung transplantation manifested by obliterative bronchiolitis.
LoCicero J; Robinson PG; Fisher M
J Thorac Cardiovasc Surg; 1990 Jun; 99(6):1059-62. PubMed ID: 2359323
[TBL] [Abstract][Full Text] [Related]
18. Bone Marrow-derived Mesenchymal Stem Cells and Chronic Allograft Disease in a Bronchiolitis Obliterans Animal Model.
Gómez de Antonio D; Campo-Cañaveral de la Cruz JL; Zurita M; Santos M; González Lois C; Varela de Ugarte A; Vaquero J
Arch Bronconeumol (Engl Ed); 2020 Mar; 56(3):149-156. PubMed ID: 31296434
[TBL] [Abstract][Full Text] [Related]
19. Donor antigen-presenting cells are important in the development of obliterative airway disease.
Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
[TBL] [Abstract][Full Text] [Related]
20. Obliterative bronchiolitis after lung transplantation: a repetitive multiple injury airway disease.
Egan JJ
Am J Respir Crit Care Med; 2004 Nov; 170(9):931-2. PubMed ID: 15504816
[No Abstract] [Full Text] [Related]
[Next] [New Search]
